US appeal court antitrust decision is good news for patent licensing
The judgment over an agreement between Endo Pharmaceuticals and Impax Laboratories comes against a backdrop of increasing FTC interest in IP strategies
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.